Flores Legarreta, Alejandra <br/><br/>
Anti TNF-α therapy in patients with relapsed and refractory Langerhans cell histiocytosis: a phase II study.  [electronic resource] 

 -  Pediatric hematology and oncology   
 - 362-368 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1521-0669 
<br/><br/><label>Standard No.: </label>10.1080/08880018.2018.1539149  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Child, Preschool<br/>Etanercept--administration & dosage<br/>Female<br/>Histiocytosis, Langerhans-Cell--drug therapy<br/>Humans<br/>Infant<br/>Male<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors